Keyphrases
Glucagon-like
95%
Gastric Emptying
64%
Somatostatin
59%
First-degree Relatives
57%
Adrenal Insufficiency
57%
Escitalopram
57%
Insulin
51%
Placebo
43%
Thyroid Peroxidase Antibody (TPOAb)
35%
Prandial
35%
Adrenal Function
34%
Depressed Patients
34%
Sex Hormone-binding Globulin
33%
Pancreatic Polypeptide
32%
Hormone Profile
32%
A1 Receptor
32%
Puberty
31%
Corticotropin-releasing Factor
30%
Receptor Signaling
28%
Thyroid Function
28%
Pregnant Women
28%
Thyroid Dysfunction
28%
Type I Diabetes
28%
Infrared Thermographic
28%
Randomized Placebo-controlled Trial
28%
Baseline-free
28%
Postnatal Period
28%
Healthy Boys
28%
Rheumatoid Arthritis
28%
Steroid Levels
28%
Prednisolone
28%
Neuroendocrine Response
28%
Digestive Function
28%
Incretin Effect
28%
Amides
28%
Glucose-dependent Insulinotropic Polypeptide
28%
Gynecomastia
28%
Sex Steroids
28%
Lung Transplantation
28%
Symptom Generation
28%
Activity Impairment
28%
Obstetric Outcomes
28%
Postgraduate Medical Education
28%
Type 1 Diabetes Mellitus (T1DM)
28%
Chromogranin A
28%
Iodine Fortification
28%
Gut Hormones
28%
Glucose Effect
28%
Hypoglycemia
28%
Thyroglobulin Antibody
28%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide-1
100%
Stomach Emptying
92%
Secretion (Process)
57%
Insulin Sensitivity
57%
Reference Value
45%
Incretin
43%
Glucose Metabolism
40%
Normal Human
39%
Insulin Release
39%
Enzyme
38%
Metabolic Regulation
34%
Glucose Homeostasis
31%
Somatostatin
31%
Sex Hormone-Binding Globulin
28%
Tincture of Iodine
28%
Growth Hormone Receptor
28%
Maturation
28%
Glucagon-Like Peptide 1 Receptor
28%
Perinatal Period
28%
Thyroid Function
28%
Insulin-Like Growth Factor 1
28%
Lipid
28%
Gastric Inhibitory Polypeptide
28%
Glomerulus Filtration
28%
Digestive Function
28%
Autoimmunity
28%
Gene Polymorphism
28%
Thyroid Hormone
28%
Cholecystokinin
28%
Exon
28%
Pancreatic Polypeptide
28%
Satiety
26%
Allele
22%
Thyroid Peroxidase
22%
Thyroglobulin
18%
Creatinine Blood Level
17%
Adolescence
17%
Receptor Gene
17%
Blood Level
15%
Medicine and Dentistry
Glucagon Like Peptide 1
70%
Cardiovascular Risk
61%
Stomach Emptying
35%
Sex Hormone Binding Globulin
33%
Hormone Release
32%
Somatostatin
31%
Glucagon Like Peptide 1 Receptor
28%
Chromogranin A
28%
Hypothyroidism
28%
Limb
28%
Gastrointestinal Hormone
28%
Acinar Cell
28%
Secretion (Process)
28%
Neuroendocrine Tumor
28%
Proton-Pump Inhibitor
28%
Body Mass Index
28%
Perinatal Period
28%
Elderly Patient
28%
Gut
28%
Peptide YY [3-36]
28%
Peptide YY [3-36]
28%
Insulin Sensitivity
28%
Enteric Feeding
28%
Lung Transplantation
28%
Pancreas Polypeptide
28%
Surgical Anastomosis
28%
Sex Hormone
28%
Congestive Heart Failure
28%
Gynecomastia
28%
Stomach Acid
28%
Gastric Bypass Surgery
28%
Gastric Bypass
28%
Sleeve Gastrectomy
28%
Pancreas Enzyme
28%
Metabolic Regulation
28%
Roux-en-Y Gastric Bypass
25%
Lean Body Weight
21%
Exocrine Pancreas
21%
Maturation
21%
Diseases
21%
Satiety
18%
